PV

Phase4 Ventures

Europe, England, United Kingdom, London

Description

Phase4 Ventures is a venture capital firm based in London that invests in development stage life science companies in the US.

Investor Profile

Phase4 Ventures has made 11 investments, with 0 in the past 12 months and 55% as lead.

Stage Focus

  • Series C (36%)
  • Series A (18%)
  • Series B (18%)
  • Series E (9%)
  • Series D (9%)
  • Series Unknown (9%)

Country Focus

  • United States (82%)
  • United Kingdom (9%)
  • Austria (9%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Biopharma
  • Medical
  • Developer Platform
  • Information Services
  • Consulting
  • Data Center
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Phase4 Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
NB
North America, Maryland, United States, Gaithersburg
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 3
MB
North America, New York, United States, New York
Co-Investments: 2
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 3
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 3
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Scottish Widows Investment Partnership
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
JL
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2

What are some of recent deals done by Phase4 Ventures?

Zosano Pharma

Fremont, California, United States

Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.

BiopharmaBiotechnologyMedical
Series BAug 6, 2009
Amount Raised: $30,000,000
OncoMed Pharmaceuticals

Redwood City, California, United States

OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.

BiotechnologyHealth CarePharmaceutical
Series BNov 4, 2008
Amount Raised: $154,000,000
Proteolix

South San Francisco, California, United States

Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CSep 8, 2008
Amount Raised: $79,000,000
Zosano Pharma

Fremont, California, United States

Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.

BiopharmaBiotechnologyMedical
Series ANov 15, 2007
Amount Raised: $90,000,000
Nabriva Therapeutics

Vienna, Wien, Austria

Nabriva Therapeutics is a biopharmaceutical company focused on the R&D of antibiotics for use in community and hospital infections.

BiotechnologyHealth CareMedical
Series UnknownSep 4, 2007
Amount Raised: $56,000,000
Phenomix

San Diego, California, United States

Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases.

BiotechnologyHealth CarePharmaceutical
Series CMar 8, 2007
Amount Raised: $55,000,000
Chroma Therapeutics

Oxton, York, United Kingdom

Chroma Therapeutics is focused on the R&D of novel small molecule drugs based on chromatin biology and cell accumulation.

BiotechnologyDeveloper PlatformInformation Services
Series CApr 3, 2006
Amount Raised: $53,000,000
ARYx Therapeutics

Fremont, California, United States

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

BiotechnologyPharmaceuticalTherapeutics
Series EFeb 10, 2006
Amount Raised: $30,400,000
Cerimon Pharmaceuticals

South San Francisco, California, United States

Cerimon Pharmaceuticals develops and commercializes therapeutics for autoimmune diseases, inflammation, and pains.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AOct 26, 2005
Amount Raised: $70,000,000
ARYx Therapeutics

Fremont, California, United States

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

BiotechnologyPharmaceuticalTherapeutics
Series DJun 1, 2004
Amount Raised: $55,000,000